Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.20 0.43% 46.60 45.00 47.40 46.60 45.60 46.40 312,228 13:05:34
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 44.9 5.5 0.8 57.5 212

Ekf Diagnostics Share Discussion Threads

Showing 1726 to 1750 of 1750 messages
Chat Pages: 70  69  68  67  66  65  64  63  62  61  60  59  Older
DateSubjectAuthorDiscuss
27/5/2020
13:47
The new orders from Longhorn are highly significant. 2 months £9.4M – mean potential 6 months to y/e £28.2M. Other sales will continue and should start to increase again as we come out of lockdown. But the full year revenue in 2019 was only £45M so IMHO EKF will blow this out of the water. DYOR
melody9999
26/5/2020
08:42
Hi Wan, Thank you for your comprehensive response.... it is greatly appreciated! Best wishes and Regards to all. Mr D
mr dexy
23/5/2020
10:26
It passed mine at 40p
hatfullofsky
23/5/2020
09:29
Anybody in or looking at GDR ? Crazy rise but some interesting tech. The board is full of nutters (of which we have our fair share here sometimes)
hatfullofsky
23/5/2020
08:37
Nothing new, but to further highlight and confirm etc - EKF Secures COVID-19 Novel Sample Collection Kit Manufacturing and Supply Contracts Patented PrimeStore® MTM sample collection device deactivates samples for safe sample handling and transport May21st,2020 EKF DIAGNOSTICS CARDIFF, UK — May 21, 2020 — EKF Diagnostics, the global in vitro diagnostics company, announces it has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows COVID-19 samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration. To support the increase in COVID-19 testing globally, a safe and easy sample collection and transport mechanism is essential—this is provided by the PrimeStore® MTM sample collection device. Full story - hTTps://www.labmanager.com/product-news/ekf-secures-covid-19-novel-sample-collection-kit-manufacturing-and-supply-contracts-22778
wan
23/5/2020
08:30
Edit to above post, CDC storage guidelines added.
wan
23/5/2020
08:15
Mr Dexy...Thanks. Yes, because there is more than a subtle difference between certain transport medias. Viral transport media (VTM) and Universal transport media (UTM) keep the viral material intact, whereas the Primestore MTM (molecular transport media) is the only transport media where the virus is inactivated at the point of collection. In the US the CDC guidelines currently recommend samples suspected of containing SARS-CoV-2 e.g. samples in VTM and UTM, be inactivated in a biological safety cabinet. Hence, using the Primestore MTM there is no potential hazard, either in the transport process or once the sample gets to the laboratory, therefore simplifying and streamlining the whole process, including the test workflow. And opening up capacity in more testing laboratories. The sample collected in the Primestore MTM is also stable at room temperature for up to 28 days, which also makes the logistics and handling less demanding with no cold chain logistics required. CDC guidelines states - Store specimens at 2-8°C for up to 72 hours after collection. If a delay in testing or shipping is expected, store specimens at -70°C or below. Apparently, the inactivation component also inactivates other enzymes and proteins that degrade nucleic acids, resulting in improved sensitivity in molecular tests, which must be another attractive attribute when being considered for pairing with a test manufacturer.
wan
22/5/2020
16:03
Hi All, Anyone know if this is the Primestore MTM ? https://news.sky.com/story/coronavirus-private-company-rises-to-exceptional-challenge-to-double-antigen-testing-11991338 "Source BioScience is processing tests in 14 hours on average, but that doesn't include the time it takes to get patient swabs to the lab. The company hopes the process will be sped up by a solution that "deactivates" COVID-19, and makes tests easier to transport. They believe they are the first in the country to use the 'transport medium', which could be "revolutionary" for scaling up testing and getting results back faster..... Director of healthcare diagnostics at Source BioScience Neil Ryan said: "You need to know the result straight away because once you've taken that test within 12 hours your result might be different if you've come into contact with somebody… the transport medium takes an element of the processing out of the initial set up. "Not only can we transport the virus at room temperature, which makes it far easier to get it in a courier up and down the motorway, it also deactivates the virus at the point the sample is put in the transport media that makes it a much safer environment for our staff handling it." Regards to all Mr D
mr dexy
21/5/2020
13:12
Anybody care to share their target price?
like2share
20/5/2020
10:36
Other unfortunate news highlights something I alluded to previously, that EKF's analysers are well placed to assist in the support efforts, excerpts follow - Coronavirus: Diabetic people offered support By Michelle Roberts Health editor, BBC News online 20th May 2020 People with diabetes are being offered help and support as a study reveals some people with the condition may be at higher risk if they catch coronavirus. Although the threat of coronavirus is still low for most diabetic people, diabetes was linked to a third of virus deaths in England from 1 March to 11 May, NHS England research shows. High blood sugar levels and obesity add to the risk. But age is a bigger risk factor. People with type 1 or 2 diabetes are strongly advised to follow the government's coronavirus advice. Data shows: Between 1 March and 11 May, there were 23,804 coronavirus-related deaths in hospitals in England 7,466 of the deceased had type 2 diabetes (which affects mostly adults) and 365 had type 1 diabetes (which most often develops in childhood) Other risk factors along with diabetes need to be taken into account When all known factors are taken into account, higher blood glucose levels and obesity are linked to higher risk In both type 1 and type 2 diabetes, men, people of black or Asian ethnicity, and people living in more deprived communities, were at higher risk In both type 1 and type 2 diabetes, those with pre-existing kidney disease, heart failure and previous stroke, were also at higher risk Doctors say if you are concerned about your diabetes during the coronavirus pandemic: Contact your GP practice or diabetes team If you have diabetes and have been contacted by your specialist eye or foot care team, please go to your appointments to receive treatment to avoid these problems getting worse. Clinics are taking extra protective measures to keep people safe The 4Ts - toilet, thirsty, tired and thinner - are signs of a life-threatening diabetic emergency, diabetic ketoacidosis or DKA. If you recognise these signs, seek urgent medical advice from your GP Practice (or 111 out of hours); if you already have diabetes, contact your diabetes team; or if you feel very unwell, call 999 If you have diabetes and see a cut or blister on your foot, it may be a sign of a foot ulcer. Call your GP practice to get it checked as soon as possible. If you do have an ulcer or other serious foot problem, you will be referred to see a specialist urgently Full story - hTTps://www.bbc.co.uk/news/health-52726328 This type of support will also be relevant in the US. And as I highlighted previously, HBA1c testing will have an important, if not increasingly important, part to play. And I would draw investors attention to the 4T's above and in particular diabetic ketoacidosis or DKA and the fact that EKF launched their FDA CLIA-waived β-ketone and glucose POC analyzer to U.S. market. Diabetic patients with abnormally high levels of βHB are at risk of developing diabetic ketoacidosis (DKA). βHB is the predominant ketone body present in the blood during DKA. For this reason it is a more appropriate test than traditional nitroprusside reaction urine tests that do not measure βHB. The STAT-Site® WB analyzer uses two different strips to provide results in just 10 seconds for β-ketones and 5 seconds for glucose allowing for clear and comprehensive management of diabetes patients displaying early signs of DKA to be quickly treated and then monitored on a regular basis. STAT-Site® WB Analyzer launch announcement - hTTps://www.ekfdiagnostics.com/fda-clia-waived-ketone-and-glucose-analyzer.html
wan
20/5/2020
10:23
The EKF holding in RENX was worth 16.8p a share at 364p for RENX. Today that holding could be worth c19p to EKF? More research needed
opener
20/5/2020
09:19
I assume EKF investors will no doubt be aware of today's Renalytix news regarding a new joint venture for scaled production of COVID-19 antibody test kits. Food for thought, I have been wondering who might get the contract for the manufacturing/assembly element of the new test?
wan
18/5/2020
11:52
Full year results may considerably exceed even recently upgraded expectations. Read more in our daily update on the impact of the coronavirus on EKF and other stocks we follow here: hxxps://www.investorschampion.com/channel/blog/coronavirus-impact-15-may-more-fund-raises-and-a-virtual-reality-music-trea
investorschampion
15/5/2020
10:25
I can see EKF following a similar trajectory to BVC over the next few sessions.It's a similar share that has been range-bound for a longtime which is about to see a material breakout. I'm expecting a move up to 60p-70p over the next few weeks. Good luck all.
tallprawn
15/5/2020
08:37
Another unfortunate (fortunate for EKF) is that I also think there will be a resurgence and possibly an increased rationale in other testing regimes (that do not include utilising PrimeStore MTM ) and in certain at risk groups such as being over weight or from an ethnicity perspective, with diabetes control being one such example e.g. HBA1c (see recent distribution agreement below) and EKF's new CLIA waived POC analyser - EKF launches FDA CLIA-waived β-ketone and glucose POC analyzer to U.S. market hTTps://www.ekfdiagnostics.com/fda-clia-waived-ketone-and-glucose-analyzer.html EKF & Tosoh Europe N.V. distribution agreement expands HbA1c POC testing reach in Middle East & Africa - hTTps://www.ekfdiagnostics.com/ekf-tosoh-europe-distribution-hba1c-poc-testing.html Some unfortunate stats - Quarter of Covid-19 deaths in English hospitals were of diabetics NHS’s first breakdown of underlying health conditions also finds 18% had dementia Denis Campbell Health policy editor Thu 14 May 2020 “The fact that more than a quarter of people who have died with Covid-19 have diabetes underlines the urgent need to ensure better protection and extra support is available to those in the clinically vulnerable groups,” said Bridget Turner, director of policy at the charity Diabetes UK. More research is needed to understand why diabetes heightens the risk of death from Covid, she said. “But until we know more, people living with diabetes should be supported to manage their condition, attend appointments as normal either online or in person at Covid-protected sites and, most importantly, should continue to have access to their local clinical team if they have concerns,” she said. Full story - hTTps://www.theguardian.com/world/2020/may/14/one-in-four-people-who-died-in-uk-hospitals-with-covid-19-had-diabetes
wan
15/5/2020
07:51
wow, just wow. this is the wrong price... big upgrades, and talking of increased capacity which i can only suggest means bigger orders coming. the recurring monthly revenue is only going one way and profits are soaring. great news
bubbleandleek
15/5/2020
07:37
Faz...Agree that there's an underlying rotten reason, but the wake-up call from this pandemic means testing will prevail for a long time, and it will very likely be a reality that we maintain a high level of preparedness for future pandemics, in terms of stock and manufacturing capacity. Also, EKF are efficiently firing on other cylinders too.
wan
15/5/2020
07:18
Great smashing super fab, that's the bullseye.
tez123
15/5/2020
07:14
you rarely post emotionally wan- but this is a fabulous update albeit for a rotten reason. However, if we are going to over come this disease it needs companies like EKF to perform. AVCT has a good update out today too.
faz
15/5/2020
07:07
What an absolutely cracking update! The additional contribution now indicated for June under the Longhorn manufacturing contract means that the Company expects to further exceed the overall management budgets for H1 2020 more confidently than was noted on 27 April. In these circumstances, the Board expects the second half of the year will see continued momentum and the full year results will exceed, perhaps considerably, its recently upgraded expectations. hTTp://uk.advfn.com/stock-market/london/EKF/share-news/EKF-Diagnostics-Holdings-PLC-Update-on-trading-and/82464655?xref=newsalert
wan
13/5/2020
15:25
Hi All, Team for new production line in place it seems.... https://www.yolkrecruitment.com/blog/2020/05/yolk-and-ekf-diagnostics-recruitment-partnership-in-reaction-to-covid-19 Would we expect an RNS to confirm production has started? Regards to all Mr D
mr dexy
12/5/2020
07:49
EKF is one my main shares and a buy on dips is my strategy, since it is still largely under the radar.
like2share
11/5/2020
09:41
I'm very positive as to both company's prospects.....
meijiman
11/5/2020
09:00
I read it, and that is not a stated fact in their release this morning. Given that the partners have not completed the analytical and clinical validation of the test, you will have to wait, but it is unlikely that a POCT would deliver accuracy of 100%. Plus , in the US the CDC guidance requires potential SARS-CoV-2 samples not inactivated to be handled in a Biological Safety Cabinet. So I am not sure how this will fit in with the POC setting. In any regard, I wish Avacta all the best, and I am sure if they get it to work, they will not be the only British success!
wan
11/5/2020
08:32
wan..have a read of the RNS from Avacta this morning. Their goal is 100% accuracy from saliva via affimers.
meijiman
Chat Pages: 70  69  68  67  66  65  64  63  62  61  60  59  Older
ADVFN Advertorial
Your Recent History
LSE
EKF
Ekf Diagno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200529 13:42:08